DisperSol Technologies LLC   Report issue

For profit Phase 1 Phase 2
Founded: Georgetown TX United States (2007)

Organization Overview

First Clinical Trial
2018
NCT03637556
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

DisperSol Technologies, LLC